News - Amgen, Financial

Filter

Current filters:

AmgenFinancial

Popular Filters

Five big pharma firms named as high performers in annual biopharmaceutical report

Five big pharma firms named as high performers in annual biopharmaceutical report

12-02-2014

Entry in emerging markets and expedient product launches are still driving the pharma market, according…

AmgenAstellas PharmaBristol-Myers SquibbFinancialMarkets & MarketingNovo NordiskPharmaceuticalResearchRoche

Amgen again tops analysts’ forecasts as profits rise 30%

Amgen again tops analysts’ forecasts as profits rise 30%

29-01-2014

Amgen, the world’s largest independent biotech firm, for the fifth reporting quarter beat analysts’…

AmgenBiotechnologyFinancial

Amgen reports 24% rise in income with 11% growth in sales

Amgen reports 24% rise in income with 11% growth in sales

23-10-2013

Amgen has announced its third quarter results with an 11% growth in sales. Its net income was up 24%…

AmgenFinancialNorth AmericaPharmaceutical

Amgen 2nd-qtr tops analysts' expectations

31-07-2013

Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, late yesterday (July 30) posted second-quarter…

AmgenBiotechnologyFinancial

Amgen profit leaps 21%, but 1st-qtr revenues disappoint

24-04-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, posted first-quarter 2013…

AmgenBiotechnologyFinancial

Briefs: Elan tender offer; German drug price review; Daiichi Sankyo pays milestone

19-04-2013

Ireland-based drugmaker Elan (NYSE: ELN) yesterday reported final results of its modified Dutch auction…

ActemraAmgenAnticalinBayerElanFinancialNovo NordiskPharmaceuticalPradaxaPricingProliaRegulationResearchRocheVictozaXarelto

Amgen to pay $24.9 million to resolve false claims on Aranesp marketing

17-04-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has agreed to pay the…

AmgenAranespBiotechnologyFinancialLegalNorth America

Amgen raises 2013 forecast, outlines strategy

08-02-2013

World leading independent biotech firm Amgen (Nasdaq: AMGN) yesterday outlined the company's long-term…

AmgenBiotechnologyFinancialMarkets & Marketing

Amgen 4th-qtr net profit plunges 16% but sales up; gets boost from fiscal cliff legislation

24-01-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest biotechnology firm, posted financials after markets…

AmgenBiotechnologyFinancialNorth AmericaPricingSensipar

News briefs: Celgene deal with Sutro; Amgen pleads guilty to misbranding

19-12-2012

US biotech firm Celgene Corp (Nasdaq: CELG) has entered a collaboration with San Francisco-based Sutra…

AmgenAranespBiotechnologyCelgeneFinancialLegalLicensingNorth AmericaSutro Biopharma

Amgen's third quarter 2012 sales and earnings top analysts' expectations

24-10-2012

The world's largest biotech company, USA-based Amgen (Nasdaq: AMGN), posted financial results for the…

AmgenBiotechnologyFinancial

Amgen beats expectations as 2nd-qtr revenues rise 13% and EPS grows 34%

27-07-2012

The world's largest independent biotech company, USA-based Amgen (Nasdaq: AMGN), saw its shares move…

AmgenBiotechnologyFinancial

Amgen beats forecasts as EPS leaps more than 20%

25-04-2012

USA-based Amgen (Nasdaq: AMGN), the world's biggest independent biotech company, posted strong first-quarter…

AmgenBiotechnologyFinancial

Lower anemia drug sales hit Amgen profit

30-01-2012

Global independent biotech leader Amgen (Nasdaq: AMGN) reported fourth-quarter 2011 results with 3% growth…

AmgenBiotechnologyFinancial

Japanese approval for Regnite and Ranmark

18-01-2012

Japanese drug major Astellas Pharma (TYO: 4503) and USA-based XenoPort (Nasdaq: XNPT) revealed yesterday…

AmgenAsia-PacificAstellas PharmaAstraZenecaBiotechnologyDaiichi SankyodenosumabFinancialNeurologicalOncologyPharmaceuticalRanmarkRegniteRegulationXenoPort

Amgen shares jump as firm unveils plans for a $5 billion stock purchase

08-11-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech firm, saw its shares leap…

AmgenBiotechnologyFinancial

Amgen 3rd-qtr 2011 profits nose dive on legal charges

25-10-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest biotechnology company, saw its third-quarter…

AmgenBiotechnologyFinancial

Amgen 2nd-qtr 2011 profits down but still top analysts estimates

01-08-2011

The world’s largest biotechnology company, USA-based Amgen (Nasdaq: AMGN) has reported second-quarter…

AmgenBiotechnologyFinancial

Back to top